The Cool Down on MSN
Ozempic-class GLP-1 drugs linked to 30% lower breast cancer odds in study of 110,000 women
"They weren't designed for cancer therapy, but they do affect many different targets." ...
New research suggests GLP-1 drugs could reduce cancer risk. A doctor breaks down how that could change public health in the ...
Cancer has often been explained through mutations in deoxyribonucleic acid (DNA) or changes in ribonucleic acid (RNA), but ...
A landmark study suggests physical activity can help cancer patients live longer. Scientists are learning why.
A University of Minnesota Medical School-led research team has discovered that a cancer signaling pathway has previously unrecognized roles in retina and brain blood vessels. The findings were ...
A Cleveland Clinic study finds Ozempic-style GLP-1 drugs may significantly slow the spread of several obesity-related cancers, including lung cancer.
A new research paper was published in Volume 17 of Oncotarget on June 3, 2026, titled "The anticancer effects of PCAIs in ...
We are celebrating that breakthrough at the precise moment Washington is taking apart the research base behind it.
Morning Overview on MSN
Daraxonrasib nearly doubled survival in metastatic pancreatic cancer, cutting the risk of death by 60% in a 500-patient trial
Patients with previously treated metastatic pancreatic cancer lived roughly twice as long on a daily oral drug called ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results